✕
Login
Register
Back to News
Eli Lilly Q1 Mounjaro Revenue +125% TO $8.70B; Zepbound +79% To $4.10B
Benzinga Newsdesk
www.benzinga.com
Neutral 55.3%
Neg 0%
Neu 55.3%
Pos 0%
Comments
No comments yet. Be the first!
Join the discussion
Login to comment
Login to comment